NERV today
$2.30-$0.08 (-3.36%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourSymmetric Triangle
1 hourSymmetric Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $15.27
Key levels
Resistance$2.66
Resistance$2.31
Support$1.96
Support$1.57
Latest news & SEC filings
EarningsMinerva Neurosciences Posts Q3 2026 Results, Business Update
SEC FilingMinerva Neurosciences, Inc. filed a report on a major company event (Form 8-K)
EarningsMinerva Neurosciences posts smaller quarterly loss than expected
All NERV news →About Minerva Neurosciences
Minerva Neurosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders. Its lead candidate, roluperidone, targets negative symptoms in schizophrenia and is being evaluated in a Phase 3 trial. The company also co-developed seltorexant for insomnia and major depressive disorder, and it operates primarily in the United States.
Based on the company's 10-K filed Mar 11, 2026.
Nasdaq · Healthcare
Minerva Neurosciences, Inc. (NERV)
What Is the Price Target for NERV?
SEPT Low Target
$10.00
SEPT Mid Target
$10.00
SEPT High Target
$14.00
Analyst Consensus
$10.00
Is NERV a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NERV.
Start Free Trial →Is NERV Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$10.00
17
Moat Score
NONE
2/9
Piotroski Score
-9.3
Altman Z-Score
What Is Smart Money Doing with NERV?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NERV Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-18347.37%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for NERV
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NERV, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:34:04 | $2.55 | 2,600 | $$7K | BUY |
| 20:34:04 | $2.55 | 1,623 | $$4K | BUY |
| 20:33:56 | $2.53 | 1,400 | $$4K | BUY |
| 19:11:57 | $2.50 | 1,500 | $$4K | SELL |
| 19:09:50 | $2.48 | 2,225 | $$6K | SELL |
5 dark pool trades shown · $$24K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Minerva Neurosciences, Inc. (NERV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NERV — frequently asked questions
What is NERV stock price today?
Minerva Neurosciences, Inc. (NERV) is at $2.30, down 3.36% (-$0.08) at the Nov 13, 2026 close.
Why is NERV stock moving today?
Latest NERV news — Nov 7, 2026: Minerva Neurosciences Posts Q3 2026 Results, Business Update · Nov 6, 2026: Minerva Neurosciences, Inc. filed a report on a major company event (Form 8-K)
What is the NERV price target?
The average analyst price target for NERV is $10.00, ranging from $10 to $14, based on 3 analysts. Latest: Minerva Neurosciences upgrade on Aug 14, 2026.
What do analysts rate NERV?
Analyst ratings for NERV: 2 Buy, 0 Hold, 0 Sell — consensus Buy.
Did NERV beat earnings?
NERV last reported on Nov 6, 2026: EPS -$0.19 vs -$0.21 expected — a beat of 9.5%.
What are NERV support and resistance levels?
Support: $1.96, $1.57, $1.30. Resistance: $2.31, $2.66, $3.43.
What are insiders doing with NERV?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on NERV?
Nov 7, 2026: Minerva Neurosciences Posts Q3 2026 Results, Business Update · Nov 6, 2026: Minerva Neurosciences, Inc. filed a report on a major company event (Form 8-K) · Nov 6, 2026: Minerva Neurosciences posts smaller quarterly loss than expected